EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation

Zuzana Sopko, Andrea Pačesová, Blanka Železná, Lenka Maletínská iD

Bioscience Reports · 22.07.2026 · 46 (7)

DOI: 10.1042/bsr20250362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioscience Reports, online erschienen am 29.06.2026. Verfasst von Zuzana Sopko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic. Hauptthemen laut MEDLINE: Neuroprotective Agents, Neuropeptides, Alzheimer Disease, Parkinson Disease. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The neuroprotective properties of several anorexigenic peptides, including leptin and glucagon-like peptide-1, are well established across models of neurodegenerative diseases. However, less is known about the role of orexigenic neuropeptides—including neuropeptide Y, agouti-related peptide, melanin-concentrating hormone, orexins, galanin, and peripherally released hormone ghrelin—that are best known for their role in energy balance and stimulation of food intake. Growing evidence highlights their broader neuroprotective properties across preclinical models of Alzheimer’s disease (AD) and Parkinson’s disease (PD). In AD, these peptides reduce hallmark pathologies such as amyloid burden, tau phosphorylation, oxidative stress, and neuroinflammation, while enhancing synaptogenesis, neurogenesis, and cognitive function. In PD models, ghrelin protects nigrostriatal dopaminergic neurons by restoring autophagic flux, suppressing endoplasmic reticulum stress-mediated apoptosis, and reducing microglial activation, whereas orexin A and B preserve tyrosine hydroxylase expression, promote neuronal excitability, and improve motor and cognitive outcomes. Taken together, these findings position orexigenic peptides as promising modulators of neurodegeneration and highlight their potential as therapeutic targets in AD and PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsNeuropeptidesAlzheimer DiseaseParkinson DiseaseNeurodegenerative DiseasesNeuroprotectionHumansAnimalsOrexins

Stichwörter der Autor:innen

Alzheimer´s diseaseneurodegenerationorexigenic peptidespreclinical models

Substanzen

Neuroprotective AgentsNeuropeptidesOrexins

Autor:innen und Institutionen

  • Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic.

ORCID-Profile: Lenka Maletínská

Förderung

  • Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences

Zitieren

APA

Sopko, Z., Pačesová, A., Železná, B., & Maletínská, L. (2026). Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation. Bioscience Reports, 46(7). https://doi.org/10.1042/bsr20250362

Vancouver

Sopko Z, Pačesová A, Železná B, Maletínská L. Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation. Bioscience Reports. 2026;46(7). doi:10.1042/bsr20250362

BibTeX
@article{Sopko2026,
  author = {Sopko, Zuzana and Pačesová, Andrea and Železná, Blanka and Maletínská, Lenka},
  title = {Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation},
  journal = {Bioscience Reports},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1042/bsr20250362}
}
Kostenlos starten →